News and Announcements
Folkestone Generates a Total Return of 30.3% & Raises Over $51.1m for its Funds
- Published July 12, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Folkestone (ASX:FLK) is an ASX listed real estate funds manager and developer providing real estate wealth solutions. Folkestone’s funds management platform, with $1.2 billion under management, offers listed and unlisted real estate funds to private clients and select institutional investors, while its on balance sheet activities focus on value‐add and opportunistic (development) real estate investments. www.folkestone.com.au
FY17 key highlights include:
- FLK generated a total return of 30.3%% outperforming the S&P/ASX300 Index which returned 13.8%;
- Launched our first seniors living fund, which acquired the Watermark Retirement Living Community at Castle Cove on Sydney’s lower North Shore. The Fund closed significantly oversubscribed raising $25.7m;
- Launched the Folkestone Wollert Development Fund, which is undertaking in JV with ID_Land, a 560 lot land subdivision in Melbourne’s northern corridor. The Fund closed significantly oversubscribed raising $25.4m;
- Folkestone Education Trust (FET), an ASX listed A-REIT that owns more than 400 childcare centres and is managed by Folkestone, generated a total return of 10.1% outperforming the S&P/ASX300 A-REIT Index which returned -5.6%;
- FLK announced its fourth joint venture with Wilmac Properties to expand its exposure to enterprise park developments. FLK and Wilmac will develop a further 2.2 hectares of FLK’s land at Altona North into 76 office/warehouse mews with an end value of circa $28m;
- FLK announced it entered into a partnership agreement with Watermark Retirement Living and the Chatswood Golf Club to develop a seniors living community integrated with a new clubhouse; and
- The Folkestone Maxim A-REIT Securities Fund was a finalist in the Lonsec/Money Management awards for Best Property and Infrastructure Fund and also for the best Emerging Manager.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
